HPV-based Screening Among Women 23-29 Years of Age

Recruiting now · Not applicable

Conditions studied: Human Papilloma Virus, Cervical Intraepithelial Neoplasia, Cervical Cancer

In brief

The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.

Key facts

Study ID

NCT05229679

Run by

Karolinska Institutet

People needed

180000

Starts

2020-11-16

Expected to finish

2038-12-31

Last updated by the study team

2025-03-19

Who can join

Age: 23 and older, up to 29. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women ages 23-29 invited to screening.

You may not qualify if…

• Women who do not show up for screening or do not consent.

Where it is running

• Region Stockholm — Stockholm, Sweden (enrolling)
• Region of Skåne — Lund, Skåne County, Sweden

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.